Bupropion: Clinical Trials

88 trials of Bupropion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed, 6 terminated, 6 unknown, 4 recruiting. 88 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 488Completed 64, Terminated 6, Unknown 6, Recruiting 4, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1

Follow Bupropion: new trials by email Literature Review of Bupropion trials Research Report on Bupropion

Trials (filtered) newest first · largest first

All 88 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV
Phase 4Not yet recruitingYale University7942027-09-302026-09-23
Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
bupropion hydrobromide, Placebo - Major Depressive Disorder
Phase 4Not yet recruitingBausch Health Americas, Inc.2462027-07-012026-09-29
Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet
Naltrexone/Bupropion, Placebo - Obesity; Drug, Obesity, Morbid
Phase 4RecruitingLaval University1082025-06-042025-08-08
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis
Phase 4Enrolling by invitationCarmen Dietvorst702025-04-142026-04-21
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
Bupropion, Nicotine replacement therapy (Nicotine patches) - Tobacco Smoking, Tobacco Withdrawal
Phase 4UnknownNational Institute of Respiratory Diseases, Mexico1342024-01-152024-02-23
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
AXS-05, Bupropion - Major Depressive Disorder
Phase 4RecruitingAxsome Therapeutics, Inc.3502023-12-272025-01-23
Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya
Tobacco Use Cessation Counselling Sessions, Bupropion, Nicotine patch - Tobacco Use Cessation, Tobacco Use
Phase 4CompletedUniversity of California, San Francisco5802023-05-162025-07-02
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Semaglutide, Orlistat, Phentermine/Topiramate - Obesity
Phase 4CompletedNovo Nordisk A/S5002023-01-192026-01-14
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline, Cipralex (escitalopram) - Major Depressive Disorder (MDD)
Phase 4RecruitingMedical University of Vienna1202022-12-012024-11-05
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
Sertraline, Bupropion - Major Depressive Disorder
Phase 4CompletedMclean Hospital572022-09-302026-10-30
Predictors of Cognitive Outcomes in Geriatric Depression
Sertraline, bupropion, desvenlafaxine - Major Depressive Disorder, Neuroticism
Phase 4Active not recruitingDavid Steffens752021-09-282026-05-22
Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
Naltrexone/bupropion, Lifestyle - Obesity
Phase 4WithdrawnOslo University Hospital2020-11-012021-03-01
Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion
Duloxetine, Bupropion - Major Depressive Disorder
Phase 4WithdrawnAlto Neuroscience2020-10-152020-10-19
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
Bupropion XL, Escitalopram - Major Depression
Phase 4CompletedEmory University182020-09-232023-12-29
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
Bupropion Hydrochloride Controlled-release, Nicotine Replacement, Questionnaire Administration - Cigarette Smoking-Related Carcinoma
Phase 4RecruitingM.D. Anderson Cancer Center20102020-08-042026-10-07
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler, Varenicline or bupropion, Contingency Management - Tobacco Use Cessation
Phase 4CompletedYale University3232020-07-272026-01-05
Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
Bupropion, Varenicline, Cognitive Behavioral Therapy - Human Immunodeficiency Virus, Smoking
Phase 4CompletedVA Office of Research and Development122019-11-182023-07-27
CPT-SMART for Treatment of PTSD and Cigarette Smoking
Smoking Cessation Cognitive Behavioral Therapy (CBT), Bupropion, Cognitive Processing Therapy - Smoking, Stress Disorders, Post-Traumatic
Phase 4CompletedVA Office of Research and Development1152019-11-072026-07-02
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion - Depression, Dementia
Phase 4CompletedCentre for Addiction and Mental Health872019-08-012024-11-25
Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
Escitalopram, Bupropion - Depression
Phase 4TerminatedUniversity of Texas Southwestern Medical Center182019-07-232023-04-18

Showing 20 of 88. Sign in to see all of them.

Conditions studied

Depressive Disorder, Major (30)  ·  Smoking Cessation (22)  ·  Depression (20)  ·  Tobacco Use Disorder (18)  ·  Smoking (7)  ·  Schizophrenia (6)  ·  Dysthymic Disorder (5)  ·  Obesity (5)  ·  Cigarette Smoking (4)  ·  Tobacco Use Cessation (4)  ·  Mental Disorders (3)  ·  Psychotic Disorders (3)  ·  Alcoholism (2)  ·  Bipolar Disorder (2)  ·  Depressive Disorder (2)

Sponsors

New York State Psychiatric Institute (9)  ·  Centre for Addiction and Mental Health (3)  ·  Duke University (3)  ·  Shanghai Mental Health Center (3)  ·  Stanford University (3)  ·  University of Wisconsin, Madison (3)  ·  VA Office of Research and Development (3)  ·  Yale University (3)  ·  Emory University (2)  ·  Indiana University (2)  ·  National Institute on Drug Abuse (NIDA) (2)  ·  North Suffolk Mental Health Association (2)  ·  Pfizer (2)  ·  University of California, San Francisco (2)  ·  University of Colorado, Denver (2)

Countries

United States (61)  ·  Canada (11)  ·  South Korea (4)  ·  Brazil (3)  ·  Mexico (3)  ·  Argentina (2)  ·  Australia (2)  ·  Bulgaria (2)  ·  Chile (2)  ·  China (2)  ·  Denmark (2)  ·  Finland (2)  ·  Germany (2)  ·  Netherlands (2)  ·  New Zealand (2)

Top investigators

A Eden Evins, MD, MPH (3)  ·  E. Jennifer Edelman, MD, MHS (2)  ·  Jonathan W. Stewart, M.D. (2)  ·  Jonathan W. Stewart, MD. (2)  ·  Peter Selby, MD, MHSc (2)  ·  Amit Anand, MD (1)  ·  Andrea H. Weinberger, Ph.D. (1)  ·  Andrew Miller, MD (1)  ·  Andrew Pipe, MD (1)  ·  Angela Moore (1)  ·  Anna Lembke, MD (1)  ·  Annelies E Jacobs, PHD (1)  ·  Aristotle Voineskos, MD (1)  ·  Boadie W Dunlop, MD (1)

Results publications

PMID 37230961, PMID 12095672, PMID 12439223, PMID 14982685, PMID 15138759, PMID 15203809, PMID 15631608, PMID 16036283, PMID 16123753, PMID 16157462, PMID 16203030, PMID 17632223, PMID 17763111, PMID 19349630, PMID 19820552, PMID 20008701, PMID 20236788, PMID 20308641, PMID 20430565, PMID 21266057, PMID 21775497, PMID 21885891, PMID 21993207, PMID 22172440, PMID 22241828, PMID 22321019, PMID 22496918, PMID 22608375, PMID 22949583, PMID 23669629, PMID 23733379, PMID 24107760, PMID 24485847, PMID 24893290, PMID 24938369, PMID 25295437, PMID 25615566, PMID 25867447, PMID 26429100, PMID 27116918, PMID 27890648, PMID 28239942, PMID 29251951, PMID 29439084, PMID 29508470, PMID 29563871, PMID 29630702, PMID 30847828, PMID 30874290, PMID 31099895

NIH funding

K23MH076049 (2), P50DA019706 (2), 2019 (1), K23MH001828 (1), P20AA015630 (1), R01CA091912 (1), R01CA243910 (1), R01DA004174 (1), R01DA017441 (1), R01DA022284 (1), R01DA030998 (1), R01GM078501 (1), R01MH068391 (1), R01MH076961 (1), R01MH085925 (1)